2023 Was a troublesome yr with the biopharma market, with various companies downsizing and restructuring their workforces to remain afloat. You'll find signs of Restoration, as mergers and acquisitions picked up through the pharmaceutical and lifestyle sciences business within the latter A part of 2023 and have ongoing their upswing https://sites.google.com/view/bio-sites/blog